![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=16132173&t=l)
glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide
Description
Study participants were mostly female (82.4%) with a median age of 52 years
![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://www.researchgate.net/profile/Inga-Bjornsdottir-2/publication/45650716/figure/fig2/AS:667822585806848@1536232720030/Structure-of-3-Hliraglutide-top-and-the-GLP-1-receptor-agonists-liraglutide-and.png)
This personalized approach transforms GLP-1 therapy from a one-size-fits-all prescription into a precision intervention tailored to your genetic makeup
![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://image.chemsrc.com/caspic/095/2230197-64-3.png)
Dietary composition matters beyond total calories
![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=16133831&t=l)
Others may require higher doses but face tolerability issues like nausea, vomiting, or gastrointestinal distress that prevent reaching therapeutic levels
![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://www.datocms-assets.com/92605/1704750414-glp-1-patents.png?auto=format&q=65)
19 Clinical data thus far has been encouraging
![glp-1 chemical structure Glucagon-like peptide 1 (7-36)amide | C151H229N41O46 | CID 16132173 Structure of [ 3 H]liraglutide](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=168432133&t=l)
